Overexpression of EEF1A2 has also been seen in breast tumors [42] and it is one of the genes in the 76-gene signature as identified in the ER-positive subset of 115 primary breast tumors that represent a strong prognostic factor for patients at high risk for developing metastases [43, 44]. The gene discussed is EEF1A2; the disease is breast neoplasm.